Acumen Historical Income Statement
| ABOS Stock | USD 1.45 0.01 0.68% |
Historical analysis of Acumen Pharmaceuticals income statement accounts such as Interest Income of 9.9 M, Depreciation And Amortization of 157.3 K or Interest Expense of 634.7 K can show how well Acumen Pharmaceuticals performed in making a profits. Evaluating Acumen Pharmaceuticals income statement over time to spot trends is a great complementary tool to traditional technical analysis and can indicate the direction of Acumen Pharmaceuticals's future profits or losses.
Financial Statement Analysis is much more than just reviewing and examining Acumen Pharmaceuticals latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Acumen Pharmaceuticals is a good buy for the upcoming year.
Acumen |
About Acumen Income Statement Analysis
Acumen Pharmaceuticals Income Statement consists of revenues and expenses along with the resulting net income or loss. It represents the profit for the accounting period attributable to Acumen Pharmaceuticals shareholders. The income statement also shows Acumen investors and management if the firm made money during the period reported. The result of an income statement is the net income that is calculated after subtracting the expenses from revenue. It is essential to investors both as an absolute measure as well as earnings per share (i.e., EPS).
Acumen Pharmaceuticals Income Statement Chart
Add Fundamental
Net Interest Income
The difference between the revenue generated from a bank's interest-bearing assets and the expenses associated with paying its interest-bearing liabilities.Interest Income
Income earned from the investment of cash or from lending money to others, including interest from bank accounts, bonds, or other interest-bearing investments.Depreciation And Amortization
The systematic reduction in the recorded value of an intangible asset. This includes the allocation of the cost of tangible assets to periods in which the assets are used, representing the expense related to the wear and tear, deterioration, or obsolescence of physical assets and intangible assets over their useful lives.Operating Income
Operating Income is the amount of profit realized from Acumen Pharmaceuticals operations after accounting for operating expenses such as cost of goods sold (COGS), wages and depreciation. Operating income takes the gross income and subtracts other operating expenses and then removes depreciation. Operating Income of Acumen Pharmaceuticals is typically a synonym for earnings before interest and taxes (EBIT) and is also commonly referred to as operating profit or recurring profit. Earnings before interest and taxes (EBIT), representing the amount of profit a company generates from its operations.Most accounts from Acumen Pharmaceuticals' income statement are interrelated and interconnected. However, analyzing income statement accounts one by one will only give a small insight into Acumen Pharmaceuticals current financial condition. On the other hand, looking into the entire matrix of income statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Acumen Pharmaceuticals. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in persons. For more information on how to buy Acumen Stock please use our How to Invest in Acumen Pharmaceuticals guide.At this time, Acumen Pharmaceuticals' Reconciled Depreciation is comparatively stable compared to the past year.
| 2022 | 2023 | 2024 | 2025 (projected) | Interest Income | 2.4M | 8.2M | 9.5M | 9.9M | Net Interest Income | 2.4M | 8.2M | 9.5M | 9.9M |
Acumen Pharmaceuticals income statement Correlations
Click cells to compare fundamentals
Acumen Pharmaceuticals Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Acumen Pharmaceuticals income statement Accounts
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 (projected) | ||
| Net Interest Income | 1K | 84K | 2.4M | 8.2M | 9.5M | 9.9M | |
| Interest Income | 1K | 84K | 2.4M | 8.2M | 9.5M | 9.9M | |
| Depreciation And Amortization | 7.9M | 4K | 169K | 184K | 165.6K | 157.3K | |
| Selling General Administrative | 1.4M | 7.3M | 12.9M | 18.8M | 21.6M | 22.7M | |
| Gross Profit | 1.4M | (4K) | (169K) | (42.3M) | (38.1M) | (36.2M) | |
| Other Operating Expenses | 9.3M | 19.6M | 45.2M | 61.1M | 70.3M | 73.8M | |
| Operating Income | (7.9M) | 61.6M | (45.2M) | (61.1M) | (55.0M) | (52.3M) | |
| Net Income From Continuing Ops | (7.3M) | (100.6M) | (42.9M) | (48.7M) | (43.9M) | (46.1M) | |
| Ebit | (7.3M) | 61.6M | (42.9M) | (51.8M) | (46.6M) | (44.3M) | |
| Research Development | 8.0M | 12.3M | 32.4M | 42.3M | 48.7M | 51.1M | |
| Ebitda | 587K | 61.6M | (42.7M) | (51.6M) | (46.4M) | (44.1M) | |
| Cost Of Revenue | 8.0K | 4K | 169K | 42.3M | 48.7M | 51.1M | |
| Total Operating Expenses | 9.3M | 19.6M | 45.2M | 61.1M | 70.3M | 73.8M | |
| Income Before Tax | (7.3M) | (100.6M) | (42.9M) | (52.4M) | (47.1M) | (49.5M) | |
| Total Other Income Expense Net | 587K | (81.0M) | 2.4M | 8.8M | 10.1M | 10.6M | |
| Net Income | (7.3M) | (181.7M) | (40.5M) | (52.4M) | (47.1M) | (49.5M) |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Acumen Stock Analysis
When running Acumen Pharmaceuticals' price analysis, check to measure Acumen Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Acumen Pharmaceuticals is operating at the current time. Most of Acumen Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Acumen Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Acumen Pharmaceuticals' price. Additionally, you may evaluate how the addition of Acumen Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.